Company & Sponsor Intelligence

Cambridge University Hospitals NHS Foundation Trust

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials3

Recruiting2

Completed0

Countries1

Therapeutic footprint

epilepsyother_neurologyparkinsons

Indexed studies

NCT05079971EAGLET: EEG vs aEEG to Improve the Diagnosis of neonataL Seizures and Epilepsy
epilepsy · United KingdomNA

NCT03240653Gaucherite - A Study to Stratify Gaucher Disease
other_neurology · United KingdomRECRUITING

NCT07157735A Trial to Test the Use of Dapansutrile, an Anti-inflammatory Medication, in People With Parkinson's Disease
parkinsons · United KingdomPHASE2

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →